Non-invasive laser therapy is laser blood irradiation improves many metabolic parameters. So, this study aims to assess the impact of Non-invasive laser therapy on lipid metabolism and renal out comes
The metabolic syndrome is a constellation of interrelated metabolic risk factors especially central obesity, dyslipidemia, hyperglycemia, which all affect worse their kidney function, and all of this causing mortality. This time line requires a quick procedure that will enable us to implement safe and non-invasive therapeutic instruments adjacent therapy for metabolic syndrome cases.
Study Type
OBSERVATIONAL
Enrollment
40
(diode laser, continuous output, in skin contact mode, 0.005W,0.2cm,beam spot area 0.03cm2, 288j/cm ,1800s) in the morning session, we measured lipid profile and kidney function before and after treatment to measure improvement
Toka
Cairo, Egypt
lipid profile change
laboratorial measurement of lipid in one mg/dl of blood
Time frame: 12 weeks following end of treatment
glomerular function range change
laboratorial measurement of glomerular function range in one ml of blood/1minute/1.73m2
Time frame: 12 weeks following end of treatment
creatinine change
laboratorial measurement of creatinine one mg/DL of blood
Time frame: 12 weeks following end of treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.